HUTCHMED (China) (HMDCF) Gross Margin Growth (3y) (2018 - 2021)
Powered by 
Analysis
HUTCHMED (China) (HMDCF) Gross Margin Growth (3y) (2018 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.93 Bn | 198.94 Bn | 7.24 Bn | -201.00 |
| 2 | Gilead Sciences | 181.03 Bn | 177.85 Bn | 6.22 Bn | 162.00 |
| 3 | Vertex Pharmaceuticals | 132.73 Bn | 124.87 Bn | 2.84 Bn | -230.00 |
| 4 | Regeneron Pharmaceuticals | 82.26 Bn | 74.27 Bn | 3.93 Bn | -168.00 |
| 5 | Argenx Se | 61.30 Bn | 56.11 Bn | 1.37 Bn | -65.00 |
| 6 | Moderna | 54.88 Bn | 49.75 Bn | 52.00 Mn | 14,836.00 |
| 7 | Alnylam Pharmaceuticals | 34.05 Bn | 30.74 Bn | 992.69 Mn | 53.00 |
| 8 | Biogen | 31.22 Bn | 29.94 Bn | 1.96 Bn | -426.00 |
| 9 | Roivant Sciences | 29.91 Bn | 29.91 Bn | 1.16 Mn | -21.00 |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 1,005.00 |
| Jun 30, 2019 | -16,028.00 |
| Jun 30, 2018 | 3,117.00 |